Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 8921-8930 Newer>

Fast Company John Ness	The Health Care Company That Hacks You RedBrick is a health care company built by people who have been working for a decade to hack human responses. They are part of a growing list of companies working to monitor and influence patients.
Chemistry World September 3, 2014 Rajesh Parishwad	Piramal exits drug discovery in India India's Piramal Enterprises is exiting its early-stage drug discovery research and focusing on late clinical development, along with its core areas such as generics and contract research services.
Chemistry World September 2, 2014 Phillip Broadwith	Exelexis slashes workforce by 70% The move follows poor results from a clinical trial of its cancer drug Cometriq (cabozantinib) in men with metastatic castration-resistant prostate cancer.
Chemistry World September 1, 2014 Maria Burke	Experimental Ebola drug 'impressive' in animal trials In the hunt for a treatment for Ebola, a new study has shown that monkeys given the experimental drug ZMapp all survived infection with the virus.
Chemistry World August 29, 2014 Sarah Houlton	Roche to buy InterMune for respiratory boost Roche is to acquire InterMune in a deal worth $8.3 billion.
Chemistry World August 29, 2014	Get prepped What should you look for in those lab workhorses: balances, stirrer plates and mills? Elisabeth Jeffries surveys the scene
Chemistry World August 27, 2014 Phillip Broadwith	Clinical collaborations drive cancer immunotherapy A joint clinical trial agreement between Merck & Co and Pfizer is the latest in a rather tangled web of tie-ups between companies with cancer drugs that harness patients' immune systems.
Fast Company Elizabeth Segran	The Eternal Problem Silicon Valley Can't Solve Last year Google launched Calico Labs, a medical company whose goal is to tackle aging and illness. Other companies have also joined in this quest.
Chemistry World August 22, 2014 Phillip Broadwith	Illumina targets cancer diagnostics Genetic sequencing heavyweight Illumina has partnered with three major pharmaceutical firms in a bid to develop a universal sequencing-based oncology test system.
Chemistry World August 20, 2014 Maria Burke	Doctors turn to experimental Ebola treatments The emergency use of an experimental medicine is highly unusual, but the WHO has declared the Ebola outbreak a public health emergency of international concern.
<Older 8921-8930 Newer> Return to current articles.